The Indo US BioTech date has been confirmed from April 30, 2018 and ended on May 3, 2018.
Indo US BioTech Developers IPO is a fixed price issue of Rs 7.29 crores. The price is ₹51 per share. The minimum lot size for an application is 2000 Shares. The minimum amount of investment required by retail investors is ₹102,000.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
April 30-May 3
Price Range
₹51 per share
Face Value
₹10 per share
GMP
₹244.70
Indo US BioTech IPO GMP
The Indo US BioTech IPO GMP is ₹244.70.
IPO Overview
The Indo-US BioTech IPO has a fixed price of Rs 7.29 crores. Bidding for the Indo-US Biotech IPO began on April 30, 2018 and finished on May 3, 2018. On May 11, 2018, the shares were listed on the BSE SME. The IPO price for Indo US BioTech is ₹51 per share.
A lot size of 2000 shares is required for an application. Retail investors must make a minimum commitment of ₹100,000. It relocated its R&D section to Gandhinagar in 2014 to continue its research efforts. As of January 31, 2018, Indo US Bio-Tech employed 45 people across multiple departments.
Indo US BioTech IPO Details
| IPO Date | April 30, 2018 to May 3, 2018 |
| Listing Date | May 11, 2018 |
| Face Value | ₹10 per share |
| Price | ₹51 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 1,430,000 shares (aggregating up to ₹7.29 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Market Maker portion | 74,000 shares |
Indo US BioTech Company Financials
| Particulars | For the year/period ended (in Rs. Lacs) | |||||
|---|---|---|---|---|---|---|
| 31-Mar-17 | 31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | ||
| Total Assets | 1,293.66 | 1,368.76 | 767.52 | 605.19 | 626.38 | |
| Total Revenue | 2,457.79 | 1,914.53 | 1,966.07 | 1,485.50 | 1,493.84 | |
| Profit After Tax | 64.99 | 35.99 | 49.59 | 25.96 | 29.94 | |
Indo US BioTech IPO Listing Details
| Listing Date | May 11, 2018 |
| BSE Script Code | 541304 |
| NSE Symbol | |
| ISIN | INE250Z01010 |
| Final Issue Price | ₹51 per share |
Company Profile
Indo US Bio-Tech Limited, based in Gujarat, was founded in 2004 and is involved in the breeding, processing, and marketing of high performing open-pollinated and hybrid agricultural seed varieties, as well as (seed testing, soil & water testing). In Junagadh, the company has its own seed testing laboratory. The corporation established an in-house research and development (R&D) unit in Modasa, District – Sabarkantha (Gujarat) for research activities aimed at producing better and more diverse seed types. On September 23, 2011, it received recognition from
the Government of India, Ministry of Science and Technology, Department of Scientific and Industrial Research Technology Bhavan, New Delhi (DSIR) for in-house R&D up to March 31, 2014. Initially, the company produced many species of oilseeds and pulses seeds; later, it added vegetable, spices and cereals seeds to its product line.
Registrar Info
| Name | Bigshare Services Pvt Ltd |
| Phone number | +91-22-6263 8200 |
| Email ID | ipo@bigshareonline.com |
| Website | ipo.bigshareonline.com |
Contact Details
| Name | Indo US Bio-Tech Limited |
| Phone number | +91 – 79 – 2749 1807 |
| Email ID | compliance@indousagriseeds.com |
| Website | indousagriseeds.com |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
